In The News,
Lindsay Bealor Greenleaf talks to HealthLeaders Media about the pitfalls of requiring list price disclosure in TV ads
[el-text]
Written by Steven Porter
***excerpt***
“Simply disclosing a drug’s list price in advertisements would be misleading because list prices don’t account for rebates and negotiated discounts provided to pharmacy benefits managers and other players in the complex supply chain,” Lindsay Bealor Greenleaf, director at ADVI Health, told HealthLeaders. “Adding to the confusion is that patients’ out-of-pocket costs will vary depending on the benefit design of an individual’s health plan.”
***end excerpt***
***
[/el-text]